0001362118-23-000048.txt : 20230713 0001362118-23-000048.hdr.sgml : 20230713 20230713151140 ACCESSION NUMBER: 0001362118-23-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230712 FILED AS OF DATE: 20230713 DATE AS OF CHANGE: 20230713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alvarez Nicholas P CENTRAL INDEX KEY: 0001802844 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 231086620 MAIL ADDRESS: STREET 1: C/O LIFEMD, INC. STREET 2: 236 FIFTH AVENUE, SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0407 4 2023-07-12 0 0000948320 LifeMD, Inc. LFMD 0001802844 Alvarez Nicholas P C/O LIFEMD, INC. 236 FIFTH AVENUE, SUITE 400 NEW YORK NY 10001 0 1 0 0 Chief Acquisition Officer 0 Common Stock 2023-07-12 4 A 0 150000 A 330000 D Employee Stock Option (Right to Buy) 7.92 2023-07-12 4 D 0 200000 D Common Stock 200000 0 D The options are being cancelled in exchange for 150,000 restricted shares, with 25,000 vesting on July 12, 2023, 50,000 vesting on January 1, 2024 and 75,000 vesting on January 1, 2025, and performance shares to be reported on settlement. The options vested and became exercisable in equal monthly tranches, based on the passage of time, over the 36 months following December 8, 2020. /s/ Nicholas P. Alvarez 2023-07-13